Tag: Aptose Biosciences Inc

Tag Visualization: Top 50 related tags by occurrence

Recent Related Articles to Aptose Biosciences Inc

Aptose Biosciences Inc. (NASDAQ:APTO) At Current Prices: Is It Worth Investing In?

Added to Collection on: 2021-02-27 14:26:15

Tags for this article:

Finance
Money
Stock market
Share trading
Financial markets
Economy of New York City
NASDAQ
Stock
Day trading
Short
Initial public offering
Aptose Biosciences Inc
NASDAQ COMPOSITE INDEX

Click the tags to see associated articles and topics

View Article Details
The Daily Biotech Pulse: Biogen Faces Another Clinical Setback, CureVac's COVID-19 Vaccine ...

Added to Collection on: 2021-06-17 12:31:23

Tags for this article:

Life Sciences
Industry economics)
Companies
Economy of New York City
NASDAQ
Biogen
Genmab
Pfizer
CureVac
Alnylam Pharmaceuticals
Protagonist Therapeutics Inc
Happiness Biotech Group Limited
DR.REDDY'S LABORATORIES LIMITED
Misonix Inc.
SATSUMA's
Alexion Pharmaceuticals Inc.
Kindred Biosciences Inc
Spruce Biosciences Inc.
ORIC Pharmaceuticals Inc.
Alzamend Neuro Inc.
LeMaitre Vascular Inc.
Zoetis Inc.
Vertex Pharmaceuticals Incorporated
Study Satsuma Pharmaceuticals, Inc.
Genmab A/S
Prometheus Biosciences Inc.
Aptose Biosciences Inc
Pharming Group N.V.
AbCellera Biologics Inc.
Natus Medical Incorporated
Shockwave Medical Inc
Inhibikase Therapeutics Inc.
Citius Pharmaceuticals Inc
Supernus Pharmaceuticals Inc
Yumanity Therapeutics Inc.
Elanco Animal Health Incorporated

Click the tags to see associated articles and topics

View Article Details
The Daily Biotech Pulse: Galapagos Sinks On Data, J&J Recalls Sunscreen Products, FibroGen ...

Added to Collection on: 2021-07-15 12:11:15

Tags for this article:

Finance
Economy of New York City
NASDAQ
Life Sciences
Biotechnology
MorphoSys
Alexion Pharmaceuticals
Nasdaq Nordic
Aytu BioPharma Inc.
Adicet Bio Inc.
BioXcel Therapeutics Inc
Achilles Therapeutics plc
Adverum Biotechnologies Inc.
Bolt Biotherapeutics, Inc.
AstraZeneca plc
Black Diamond Therapeutics, Inc.
Avenue Therapeutics Inc.
Baudax Bio Inc.
Akero Therapeutics Inc.
Aptose Biosciences Inc
Celldex Therapeutics Inc.
Allogene Therapeutics Inc.
Alexion Pharmaceuticals Inc.
PLx Pharma Inc
Bristol-Myers Squibb Company
Zoetis Inc.
Celyad Oncology SA
Moderna, Inc.
Allovir Inc
Allena Pharmaceuticals Inc
4d molecular therapeutics
AbCellera Biologics Inc.

Click the tags to see associated articles and topics

View Article Details
The Daily Biotech Pulse: Ardelyx Sinks On Regulatory Setback, AnPac Issues Positive ...

Added to Collection on: 2021-07-20 12:11:15

Tags for this article:

Life Sciences
Industry economics)
Economy of New York City
NASDAQ
Biotechnology
MorphoSys
Phio Pharmaceuticals
Amneal Pharmaceuticals
Sarepta Therapeutics
DURECT Corporation
4D pharma plc
Aytu BioPharma Inc.
Agile Therapeutics Inc.
Biophytis SA
Concert Pharmaceuticals Inc.
Atreca Inc.
Biomea Fusion Inc.
Adverum Biotechnologies Inc.
Centessa Pharmaceuticals Limited
Alzamend Neuro Inc.
Avenue Therapeutics Inc.
Baudax Bio Inc.
Adaptimmune Therapeutics plc
Coherus Biosciences Inc.
Assembly Biosciences Inc
Aptose Biosciences Inc
Forward Pharma A/S
AZURRX BIOPHARMA INC.
Aerovate Therapeutics Inc.
CytomX Therapeutics Inc.
ResMed Inc.
Design Therapeutics Inc.
Assertio Holdings Inc.
Cytokinetics Incorporated
Arca Biopharma Inc
Athersys Inc.
Legend Biotech Corporation
Cogent Biosciences Inc.
Moderna, Inc.
Edgewise Therapeutics Inc.
Allena Pharmaceuticals Inc
Athira Pharma Inc.

Click the tags to see associated articles and topics

View Article Details
The Daily Biotech Pulse: Lilly Reorganizes Business Units In Neuroscience Focus, Helius ...

Added to Collection on: 2021-08-17 15:31:06

Tags for this article:

Life Sciences
Biotechnology
Industry economics)
Economy of New York City
NASDAQ
Gilead Sciences
Incyte
Phio Pharmaceuticals
Eli Lilly and Company
MorphoSys
Diffusion Pharmaceuticals
N-Shares
4D pharma plc
Agile Therapeutics Inc.
Acurx Pharmaceuticals Inc.
Absci Corporation
Acadia Pharmaceuticals Inc
Novo Nordisk A/S
Pfizer Inc.
Aptinyx Inc.
Adverum Biotechnologies Inc.
West Pharmaceutical Services Inc.
23andMe
Achieve Life Sciences Inc
ABVC BioPharma Inc.
Aptose Biosciences Inc
NanoVibronix Inc.
Laboratory Corporation of America Holdings
Gilead Sciences Inc.
ResMed Inc.
Arena Pharmaceuticals Inc.
Aravive Inc
Akoya Biosciences Inc.
Applied Genetic Technologies Corporation
Monte Rosa Therapeutics Inc.
Adaptive Biotechnologies Corporation
Angion Biomedica Corp
Johnson & Johnson
Accelerate Diagnostics Inc.
Quest Diagnostics Incorporated
GlaxoSmithKline plc
Bio-Rad Laboratories Inc.

Click the tags to see associated articles and topics

View Article Details
AUPH Equity Alert: ROSEN, Top Ranked Investor Counsel, Encourages Aurinia ...

Added to Collection on: 2022-03-24 06:52:09

Tags for this article:

Health sciences
Health
Chemical compounds
Orphan drugs
Drug discovery
CD135
Acute myeloid leukemia
Clinical trial
Gilteritinib
7+3
Midostaurin
Devimistat
Aptose Biosciences Inc

Click the tags to see associated articles and topics

View Article Details
Aptose to Present at 2022 RBC Capital Markets Global Healthcare Conference | Financial Post

Added to Collection on: 2022-05-03 20:36:23

Tags for this article:

Clinical medicine
Cancer
Medicine
Acute myeloid leukemia
Myelodysplastic syndrome
Protein kinase inhibitors
Antibody-drug conjugates
Cancer treatments
Orphan drugs
Devimistat
Midostaurin
Aptose Biosciences Inc

Click the tags to see associated articles and topics

View Article Details
Aptose to Present at 2022 RBC Capital Markets Global Healthcare Conference | The Star Phoenix

Added to Collection on: 2022-05-03 18:11:05

Tags for this article:

Clinical medicine
Cancer
Medicine
Acute myeloid leukemia
Myelodysplastic syndrome
Protein kinase inhibitors
Antibody-drug conjugates
Cancer treatments
Orphan drugs
Devimistat
Midostaurin
Aptose Biosciences Inc

Click the tags to see associated articles and topics

View Article Details
Q2 2022 EPS Estimates for Aptose Biosciences Inc. (NASDAQ:APTO) Increased by Analyst

Added to Collection on: 2022-05-12 10:40:54

Tags for this article:

Financial markets
Finance
Financial economics
Stock market
Price?earnings ratio
Stock
Short
Aptose Biosciences Inc

Click the tags to see associated articles and topics

View Article Details
Aptose Biosciences (NASDAQ:APTO) Price Target Cut to $5.00 - Defense World

Added to Collection on: 2024-02-03 20:35:38

Tags for this article:

Stock market
Equity securities
Penny stock
Securities research
Stock
Short
Aptose Biosciences Inc
Aptose Biosciences

Click the tags to see associated articles and topics

View Article Details